Dashboard
Manage Tickers

TFFPTFF Pharmaceuticals, Inc.

Nasdaq tffpharma.com


$ 2.96 $ -0.13 (-4.21 %)    

Friday, 26-Apr-2024 15:57:25 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 430.98 $ -2.17 (-0.5 %)
DIA $ 383.42 $ 0.23 (0.06 %)
SPY $ 509.18 $ -1.08 (-0.21 %)
TLT $ 88.52 $ -0.14 (-0.16 %)
GLD $ 215.88 $ -0.74 (-0.34 %)
$ 2.9215
$ 2.99
$ 0.00 x 0
$ 0.00 x 0
$ 2.96 - $ 2.99
$ 2.51 - $ 21.25
34,088
na
7.36M
$ 2.46
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-28-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-31-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-11-2022 03-31-2022 10-Q
9 03-24-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-13-2021 03-31-2021 10-Q
13 03-10-2021 12-31-2020 10-K
14 11-05-2020 09-30-2020 10-Q
15 08-13-2020 06-30-2020 10-Q
16 05-14-2020 03-31-2020 10-Q
17 03-27-2020 12-31-2019 10-K
18 12-09-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

tff-pharmaceuticals-announces-additional-data-from-the-tacrolimus-inhalation-powder-tff-tac-phase-2-trial-following-oral-presentation-at-the-ishlt-44th-annual-late-breaking-clinical-science-abstract-sessions
TFF Pharmaceuticals Announces Additional D...
04/15/2024 11:11:19

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) ("the Company"), a clinical-stage biopharmaceutical company focused on developi...

tff-pharmaceuticals-q4-eps-201-beats-212-estimate-sales-11433k-beat-10000k-estimate
TFF Pharmaceuticals Q4 EPS $(2.01) Beats $...
03/28/2024 20:20:29

TFF Pharmaceuticals (NASDAQ:TFFP) reported quarterly losses of $(2.01) per share which beat the analyst consensus estimate of $...

roth-mkm-maintains-buy-on-tff-pharmaceuticals-lowers-price-target-to-44
Roth MKM Maintains Buy on TFF Pharmaceutic...
03/28/2024 17:01:12

Roth MKM analyst Jonathan Aschoff maintains TFF Pharmaceuticals (NASDAQ:TFFP) with a Buy and lowers the price target from $5...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
03/27/2024 20:31:13

tff-pharmaceuticals-announces-updated-data-from-tacrolimus-inhalation-powder-voriconazole-inhalation-powder-clinical-programs-says-eight-of-eight-patients-successfully-transitioned-from-oral-tacrolimus-to-tff-tac-with-no-sign-of-acute-rejection-at-reduced-systemic-exposures
TFF Pharmaceuticals Announces Updated Data...
03/27/2024 20:05:19

tff-pharmaceuticals-announces-oral-presentation-of-interim-data-from-the-phase-2-study-of-tacrolimus-inhalation-powder-for-the-prevention-of-lung-transplant-rejection-at-the-44th-annual-ishlt-2024-meeting
TFF Pharmaceuticals Announces Oral Present...
03/25/2024 13:16:22

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing i...

tff-pharmaceuticals-announces-12m-registered-direct-offering-of-147500-shares-at-800share
TFF Pharmaceuticals Announces $1.2M Regist...
03/20/2024 16:02:39

tff-pharmaceuticals-announces-clinical-programs-update-and-strategic-prioritization-company-to-prioritize-tff-tac-program-based-on-phase-2-data
TFF Pharmaceuticals Announces Clinical Pro...
03/20/2024 13:10:28

Company to Prioritize Clinical Development of Tacrolimus Inhalation Powder (TFF TAC) based on Positive Phase 2 Data, the Potent...

tff-pharmaceuticals-to-present-data-from-phase-2-trial-of-voriconazole-inhalation-powder-for-treatment-of-invasive-pulmonary-aspergillosis-at-11th-advances-against-aspergillosis--mucormycosis-conference
TFF Pharmaceuticals To Present Data From P...
01/24/2024 13:17:10

tff-pharmaceuticals-announces-acceptance-of-late-breaking-abstract-for-presentation-at-the-44th-annual-international-society-for-heart-and-lung-transplantation-2024-meeting
TFF Pharmaceuticals Announces Acceptance O...
01/09/2024 13:13:17

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing i...

bluebird-bio-vertex-energy-and-other-big-stocks-moving-lower-on-tuesday
Bluebird Bio, Vertex Energy And Other Big ...
12/19/2023 15:19:40

U.S. stocks traded higher, with the Dow Jones index gaining around 150 points on Tuesday. Shares of bluebird bio, Inc. (NASDA...

tff-pharmaceuticals-announced-initial-data-from-its-ongoing-phase-2-trials-of-tff-vori-and-tff-tac-along-with-clinical-data-from-the-ongoing-tff-vori-expanded-access-program
TFF Pharmaceuticals Announced Initial Data...
12/19/2023 11:05:25

tff-pharmaceuticals-to-hold-conference-call-and-webcast-to-review-initial-data-from-ongoing-phase-2-trials-of-tff-vori-and-tff-tac-on-dec-19-at-830-am-et
TFF Pharmaceuticals To Hold Conference Cal...
12/18/2023 21:04:15

tff-pharmaceuticals-announces-reverse-stock-split-at-a-ratio-of-1-post-split-share-for-every-25-pre-split-shares
TFF Pharmaceuticals Announces Reverse Stoc...
12/15/2023 12:04:20

tff-pharmaceuticals-q3-eps-009-beats-011-estimate-sales-23476k-beat-5000k-estimate
TFF Pharmaceuticals Q3 EPS $(0.09) Beats $...
11/14/2023 21:52:00

TFF Pharmaceuticals (NASDAQ:TFFP) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $...

earnings-scheduled-for-november-14-2023
Earnings Scheduled For November 14, 2023
11/14/2023 13:23:43

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue o...

preview-tff-pharmaceuticalss-earnings
Preview: TFF Pharmaceuticals's Earnings
11/13/2023 16:01:57

tff-pharmaceuticals-announces-publication-of-data-demonstrating-feasibility-of-intranasal-delivery-of-monoclonal-antibodies-with-thin-film-freezing
TFF Pharmaceuticals Announces Publication ...
11/08/2023 22:18:09

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) ("the Company"), a clinical-stage biopharmaceutical company focused on developi...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
08/28/2023 21:31:25

why-phenomex-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why PhenomeX Are Trading Lower By Around 2...
08/15/2023 18:01:16

Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) jumped 85.4% to $0.1267 after the company and Farm 7 Group announced ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION